HCG11 and non-small cell lung carcinoma: In conclusion, this study demonstrated that lncRNA HCG11 expression was decreased in NSCLC tissues and cells, and abnormal expression of lncRNA HCG11 was related to adverse clinical outcomes in NSCLC patients.